Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-29 to 2025-02-20
Current total value of award: $61704.3
Description: 4567099442!XIAFLEX 0.9 MG VIALS